The PRONTO study is investigating new ways to rapidly identify people who have experienced a large vessel occlusion (LVO) stroke, caused by a blockage in one of the brain’s major arteries.

Patients experiencing an LVO stroke may require an emergency procedure known as a thrombectomy, which removes blood clots and restores blood flow to the brain.

The faster the procedure is delivered, the greater the patient’s chances of survival and recovery.

Directing patients to specialist care

Christopher Price, Professor of Stroke and Applied Health Research at Newcastle University, and Dr Lisa Shaw, Reader in Stroke Research, are co-leading the study.

Professor Price said: “Results from studies using the LVOne test in hospital were promising, so we're now hoping to show that it can help to identify patients suitable for thrombectomy whilst they are still in the ambulance.

"If the study is a success, then the test would speed up treatment and improve recovery for a large number of stroke survivors.”

Currently, ambulance clinicians have no specific test available to reliably identify an LVO stroke before arriving at hospital. The PRONTO study hopes to change that.

The trial combines a simple fingerpick blood test, known as the LVOne test and developed by Upfront Diagnostics Ltd, with direct communication between ambulance crews and hospital specialists.

The test measures levels of two blood biomarkers – d-dimer and GFAP – which previous hospital-based research suggests may help identify patients experiencing an LVO stroke.

By identifying suitable patients while they are still in the ambulance, the study could enable them to be taken directly to specialist centres capable of performing thrombectomy, avoiding delays caused by additional tests at local hospitals.

At present, thrombectomy services are only available in a limited number of regional stroke centres, meaning many patients first attend a local hospital for assessment before being transferred for treatment if required.